Six commercially available angiotensin II AT1 receptor antibodies are non-specific. - Wikidata - wikimedia - TriplyDB

Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

http://www.wikidata.org/entity/Q36429006

about

Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma Update on angiotensin AT2 receptors.Ang II-AT2R increases mesenchymal stem cell migration by signaling through the FAK and RhoA/Cdc42 pathways in vitro.Western Blotting Inaccuracies with Unverified Antibodies: Need for a Western Blotting Minimal Reporting Standard (WBMRS).Depletion of endothelial or smooth muscle cell-specific angiotensin II type 1a receptors does not influence aortic aneurysms or atherosclerosis in LDL receptor deficient mice.Commercially available angiotensin II At₂ receptor antibodies are nonspecific.Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system Fibroblast Angiotensin II Type 1a Receptors Contribute to Angiotensin II-Induced Medial Hyperplasia in the Ascending Aorta Regulation of angiotensin II type 2 receptor gene expression in the adrenal medulla by acute and repeated immobilization stress.ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective Commentary.Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.Surgery-Induced Hippocampal Angiotensin II Elevation Causes Blood-Brain Barrier Disruption via MMP/TIMP in Aged Rats.Aging-related impairment of urine-concentrating mechanisms correlates with dysregulation of adrenocortical angiotensin type 1 receptors in male Fischer rats.Decreased renal AT1 receptor binding in rats after subtotal nephrectomy: PET study with [(18)F]FPyKYNE-losartan Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways.Effects of exercise training on SFO-mediated sympathoexcitation during chronic heart failure.Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system.Antibodies for immunolabeling by light and electron microscopy: not for the faint hearted.Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies Crosstalk between angiotensin and the nonamyloidogenic pathway of Alzheimer's amyloid precursor protein.A Unique "Angiotensin-Sensitive" Neuronal Population Coordinates Neuroendocrine, Cardiovascular, and Behavioral Responses to Stress.Response to lack of specificity of commercial antibodies leads to misidentification of angiotensin type-1 receptor protein.Correction for Fernández de Castro et al., Reovirus Forms Neo-Organelles for Progeny Particle Assembly within Reorganized Cell Membranes.Impaired Aortic Contractility to Uridine Adenosine Tetraphosphate in Angiotensin II-Induced Hypertensive Mice: Receptor Desensitization?Angiotensin II Type 1 Receptor Mechanoactivation Involves RGS5 (Regulator of G Protein Signaling 5) in Skeletal Muscle Arteries: Impaired Trafficking of RGS5 in Hypertension.Maternal-pup interaction disturbances induce long-lasting changes in the newborn rat pulmonary vasculature.Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli.Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors.Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.Exercise training modulates the hepatic renin-angiotensin system in fructose-fed rats.A Color Segmentation-Based Method to Quantify Atherosclerotic Lesion Compositions with Immunostaining.The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?

P2860

Q28081615-9EDCC3B9-8E5F-4F7D-96FF-591E72BCD04D Q28550525-2EDF337E-0E8E-42BC-8665-45002E45EC83 Q30275321-069DB3CA-0B44-4B3A-AAE9-DE6C13099CFE Q33896450-57E12725-BD09-4602-BE29-0021A46E7B86 Q34490107-251A96C5-00AD-49A9-9D94-CDB33C793E67 Q34511040-5312FB47-9583-4CE1-891D-84C1F5050208 Q34809342-F5089EF4-F95D-4EC9-979C-8197A054C2DC Q35656144-F9017897-5B18-4F4D-B3F2-A41373EDC328 Q36004556-3A2A8875-CEB5-4FFC-94CF-9BC49BEBFF23 Q36327023-AC75EBAF-8878-4B07-B43A-E8674189531E Q36339485-64A82870-C9D7-486B-A80E-774AC52DD164 Q36733839-D93DB9A3-39C1-4B63-B47D-789C1F48D0AE Q36764034-98A604DC-BADE-42F0-9E9B-450D0A80DF77 Q36834432-64CE57EF-577B-45F5-9F72-21F0E92A64C3 Q36902495-BD49DEFF-C827-4ED8-A538-EBCA597B7FE6 Q37033868-42D38EEC-49F9-4271-A402-A3365BA97BEC Q37454928-5BB635B0-97F3-419C-A289-4F626518E1CB Q37575972-4C8D1F6E-EB61-4A4B-BBE8-D285C0E8D5BF Q38100285-DA662A6A-8F62-492E-A34B-FBD879B199E0 Q38242657-3C587835-BB0B-45E5-8F4B-5B5BA98F23C1 Q38694797-14981F29-76F7-4DF9-9B68-AF8E3E12C0DB Q39012575-25926923-1F42-4F61-865C-D12240752185 Q41666143-E67EF70E-2500-4269-994B-7468B08C3F71 Q42426667-BDC88D44-2738-4D94-BC0E-6233FDA65A59 Q43141651-626042C8-6384-4243-BECB-110DC05D39D9 Q45049857-DC4BCAC6-5191-4373-BB55-F0724260C015 Q45070797-819D0911-3021-44D9-BB13-C82526036B79 Q46674014-BA310A3B-0B77-4349-AB6C-1B04372888FE Q46792828-475BAA09-2FF3-4145-91F6-334859C530E9 Q48106483-FC7A647F-6136-4FBF-AE0F-C74D87C00B20 Q48657794-0D8E2677-FC1C-4112-A791-D0479181B623 Q50462945-52A5E241-3197-4B0A-802A-F54F8745238C Q50937968-5A54F31E-80F3-47C4-9F74-8C5CBB9C8368 Q51004437-B9DBDDB1-CD19-48A2-9465-48DDCA3EE25C Q52347539-76B9FD25-EF70-49BF-9323-AEC7F71257E7

P2860

Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

http://www.wikidata.org/entity/Q36429006

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

@ast

Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

@en

type

label

Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

@ast

Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

@en

prefLabel

Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

@ast

Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

@en

P1433

Q36429006-0960C78D-BC78-49B8-81C4-0AA49D9F11BD

P1476

Q36429006-98B47FFB-FCF8-4459-9305-7AD64E879E5C

P2093

Q36429006-1120B803-06AA-4C6A-A7AB-5561150CB86F

Q36429006-31935A16-716C-4E6A-9620-7E917DC24942

Q36429006-352B978F-8B9A-4CC2-B3DF-0CAC63239389

Q36429006-C9B9FEB8-D3AD-4C41-AA0B-799BC11CF5BF

Q36429006-F50BF09D-A1A5-4BF7-9B2F-15CE3C8984CC

P2860

Q36429006-0925BBFF-D7C4-4BC8-91D8-4D5771BC4116

Q36429006-0E608DD5-22A8-4D92-BD69-58178D05731C

Q36429006-19F7BA75-C32C-49F0-8BA5-D19EE7D5973E

Q36429006-1FFC1EA0-1487-472E-892B-0272668B6DEC

Q36429006-214B1866-0B33-4F95-B1C6-D2FD347E8B44

Q36429006-21D4A313-3022-4017-ABB6-C98AE2412FDC

Q36429006-295F4A30-4E50-42B9-9C63-725CDE8C05F2

Q36429006-2A211283-9DD5-4C07-8F68-6503CAFEA769

Q36429006-34521C8E-B84E-4D32-BA78-404A83F5720E

Q36429006-3A9096DA-A5DB-49F0-B70D-136770BF01BA

P2888

Q36429006-1601BAF0-7A90-484A-B64B-ACE8A3A8C020

P304

Q36429006-30B07410-3F8A-477E-A724-1241B503C8FE

P31

Q36429006-0D1BF1C3-1E59-4049-8EF8-32F07F3A1E9F

P356

Q36429006-5A84072A-09B1-4F5E-BA5D-9FB320E70E7A

P433

Q36429006-B3BD4CA7-9E1E-4976-B033-C664884C09B7

P478

Q36429006-835A96C8-DE6D-45B6-976F-64CDD644B341

P577

Q36429006-DC13AB74-AF98-428C-9C32-AF38AD2A1A8F

P5875

Q36429006-F9F57A9A-A0AD-491D-B142-1060038FFC9F

P698

Q36429006-420E9B17-4DB8-476E-B718-A7B95454310A

P921

Q36429006-3A72882B-691D-4FD3-BE3C-024C811BA970

P932

Q36429006-65CCF05D-BDE5-46FA-8209-EAEB8DBBB0CE

P356

S10571-012-9862-Y

P1433

Cellular and Molecular Neurobiology

P1476

Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

@en

P2093

Enrique Sanchez-Lemus

http://www.w3.org/2001/XMLSchema#string

Greti Aguilera

http://www.w3.org/2001/XMLSchema#string

Juan M Saavedra

http://www.w3.org/2001/XMLSchema#string

Julius Benicky

http://www.w3.org/2001/XMLSchema#string

Roman Hafko

http://www.w3.org/2001/XMLSchema#string

P2860

The angiotensin receptor subtype AT1A predominates in rat forebrain areas involved in blood pressure, body fluid homeostasis and neuroendocrine control

Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome.

Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II.

Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Regulation of blood pressure by the type 1A angiotensin II receptor gene.

Physiology of local renin-angiotensin systems.

Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice.

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

A guide to the perplexed on the specificity of antibodies.

In vivo Angiotensin II AT1 receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland.

P2888

s10571-012-9862-y

P304

1353-1365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10571-012-9862-Y

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230585493

http://www.w3.org/2001/XMLSchema#string

P698

22843099

http://www.w3.org/2001/XMLSchema#string

P921

P932

3508356

http://www.w3.org/2001/XMLSchema#string